Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
The restaurant stock cut its payout a year ago.
Over the past six months, Align Technology has been a great trade, beating the S&P 500 by 5.5%. Its stock price has climbed to $177.15, representing a healthy 12.2% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Shares of Palo Alto Networks (NASDAQ:PANW) are up 9% to $331.91 at midday Monday, leading a sharp rally across cybersecurity platform leaders. CrowdStrike (NASDAQ:CRWD) stock is up 7% to $747.84, and Okta (NASDAQ:OKTA) stock is up 5% to $130.23. The synchronized move caps a powerful run for the group. Year to date (YTD), Palo Alto ... Palo Alto Networks Surges 9%, CrowdStrike Rises 7%, Okta Gains 5%: Can the Cybersecurity Rally Justify Its Valuations?
Summer 2026 pullbacks have created potential entry points in AMPX, ORCL, SNOW, CRM, and ZS, with analyst consensus targets implying 55% to 80% upside across the group.
The Wall Street firm reportedly said the former crypto miner is emerging as a key AI data center infrastructure play, with its valuation still lagging its long-term growth prospects.

Scott Melker breaks down Strategy's (MSTR) new approach to bitcoin (BTC-USD). "The Daily Wolf with Scott Melker" airs every day at 12:00 p.m. Tune in for your daily dose of all things crypto. Make sure to also check out Yahoo Finance's new crypto hub to find the latest crypto-related news.
HIVE Digital Technologies Ltd. (NASDAQ:HIVE) is one of the 8 High Growth Penny Stocks to Buy. On June 25, 2026, HIVE Digital Technologies Ltd. (NASDAQ:HIVE) announced that HIVE Bermuda 2026, its wholly-owned subsidiary, intends to offer $100M aggregate principal amount of 0% exchangeable senior notes due 2031. The private offering is subject to market conditions […]
Okta benefits from identity security demand, 20,000+ customers, and AI offerings, but SentinelOne stands out for faster growth and platform momentum.
Ethena says USDe now reaches BlackRock's Aladdin institutions as ENA rallies, with BUIDL backing its white-label product.
A wannabe Pokémon reseller is stuck with a bunch of unsold cards and $15K in debt. Here’s what Dave Ramsey has to say about this “stupid” life decision.
Is ASX stock the better buy over AMKOR as AI packaging momentum, stronger earnings growth and lower valuation give it an edge?
Something may boost the stock around that time.
The bitcoin treasury company adopted a new Digital Credit Capital Framework that includes up to $1B in common stock repurchases and a bitcoin monetization program
Carvana Co. (NYSE:CVNA) is one of the 10 Interest Rate Sensitive Stocks to Buy Now. On June 12, 2026, RBC Capital lowered its price target on Carvana Co. (NYSE:CVNA) to $85 from $92 and kept an Outperform rating. RBC Capital updated its retail unit cohort model to gauge market share gain expectations embedded in Street […]
AvalonBay Communities, Inc. (NYSE:AVB) is one of the 10 Interest Rate Sensitive Stocks to Buy Now. On June 16, 2026, Truist raised its price target on AvalonBay Communities, Inc. (NYSE:AVB) to $202 from $201 and kept a Buy rating. Truist adjusted its model with expectations for 1.3% year-over-year same-store revenue growth in 2026 and 3.9% […]
Markets have become increasingly sensitive to any headline that hints at government spending or political influence. Defense contractors, AI companies, and cybersecurity firms can all move sharply on a single news report, even when the underlying information isn’t actually new. That happened again today after CNBC reported that President Trump bought between $1 million and ... Axon Soars on Trump Stock Purchase Highlighting Insider Trading Issues
AI is supplanting the consumer as the driver of US economic growth.
The company hopes to obtain approval for its air taxi soon, and that would certainly be a game changer for the stock.
AbbVie (NYSE:ABBV) received positive opinions from the European Medicines Agency's CHMP for RINVOQ in severe alopecia areata and non-segmental vitiligo. If approved, RINVOQ could become the first systemic therapy for non-segmental vitiligo in Europe. The new indications target areas with high unmet medical need in dermatology and immunology. AbbVie has been active across immunology, gastroenterology and virology, and RINVOQ is already a core asset in its portfolio. These fresh CHMP...
A blockbuster deal positions the company to compete more directly with SpaceX.
TTM (TTMI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
RTX (RTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Chevron reached the market before ExxonMobil.
VICR's 621% surge reflects rising AI power demand, proprietary technologies, IP licensing growth and manufacturing leverage supporting long-term gains.
In the past five years, this top healthcare stock has risen by close to 130%.
Palo Alto Networks is expanding its AI security platform through partnerships that enhance cyber protection and target regulated industries.
JNJ gets a positive CHMP opinion for Tecvayli in combination with Darzalex SC for treating relapsed/refractory multiple myeloma after one prior therapy.
Strategy is scrambling to reassure investors amid a slump in the price of its primary means for funding crypto purchases.